Doximity Inc (NYSE:DOCS) Passes Quality Investing Screen with Strong Profitability and Zero Debt
8h agoen
From the article
Doximity (DOCS) passes the Caviar quality screen with 177% ROIC, zero debt, and 32% EBIT growth outpacing revenue. A top-tier healthcare tech stock with strong profitability and fair valuation.
Continue reading on ChartMillYou might also wanna read
Two Drugmakers Own 90% of the Obesity Boom. One Fund Owns Both for 0.59%
24/7 Wall St.·2h ago
GlaxoSmithKline announces sale of shares in Quest Diagnostics Inc.
GSK·17y ago
IT stocks with Strong Buy Quant Ratings for 60+ days: MU, CLS, CRDO highlighted
The article highlights information technology stocks that have maintained Seeking Alpha Strong Buy Quant Ratings for at least 60 days. It me
seekingalpha.com·1mo agoHims & Hers Health vs. Teladoc Health: Which Healthcare Stock Is a Better Buy in 2026?
Bars·2d ago
CAVA Group (NYSE: CAVA) Makes Watchlist While NVR (NYSE: NVR) And Applied Digital (NASDAQ: APLD) Draw Sell Ratings
Foreign Policy Journal·4h ago
Dividend ETF Comparison: SCHD (U.S.) vs SCHY (International) Quality Screens and Distributions
This article compares two dividend-focused ETFs: SCHD (U.S. dividend stocks) and SCHY (international developed-market dividend stocks). SCHD
briefly.co·20d ago
Comments
Sign in to join the conversation.
No comments yet. Be the first.